𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Zoladex plus tamoxifen versus zoladex alone in premenopausal metastatic breast cancer

✍ Scribed by Nicholson, R.I.; Walker, K.J.; Dixon, A.R.; Robertson, J.F.R.; Blamey, R.W.

Book ID
123229134
Publisher
Elsevier Science
Year
1990
Weight
134 KB
Volume
26
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined endocrine effects of LHRH agoni
Combined endocrine effects of LHRH agonist (Zoladex®) and tamoxifen (Nolvadex®) therapy in premenopausal women with breast cancer
✍ Mr J. F. R. Robertson; K. J. Walker; R. I. Nicholson; R. W. Blamey 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB 👁 2 views

Abstract In premenopausal women with breast cancer, the use of the luteinizing hormone releasing hormone agonist, goserelin, results in the production of serum levels of oestradiol equivalent to those after surgical oöphorectomy or in postmenopausal women. The standard first line hormonal treatment